Jubilant Ingrevia Ltd

Jubilant Ingrevia Ltd

₹ 599 -0.02%
12 Jul - close price
About

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.

Jubilant Ingrevia’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. [1]

Key Points

Leadership[1]
# 40+ years of legacy in Chemicals space, started in 1978
# Global player in Pyridine + Beta, Vitamin B3 and Acetic Anhydride.
# Serves 15 of the top 20 Global Pharma & 7 of the top 10 Global Agrochemical companies.
# Leading Low-Cost provider

  • Market Cap 9,539 Cr.
  • Current Price 599
  • High / Low 614 / 399
  • Stock P/E 52.2
  • Book Value 172
  • Dividend Yield 0.83 %
  • ROCE 9.78 %
  • ROE 6.77 %
  • Face Value 1.00

Pros

  • Company has been maintaining a healthy dividend payout of 28.6%

Cons

  • Company has a low return on equity of 13.1% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
684 1,145 1,223 1,286 1,296 1,166 1,304 1,158 1,145 1,075 1,020 966 1,074
567 863 1,027 1,074 1,153 1,025 1,151 1,007 1,043 958 902 871 983
Operating Profit 117 282 195 213 142 141 153 151 102 117 118 96 91
OPM % 17% 25% 16% 17% 11% 12% 12% 13% 9% 11% 12% 10% 8%
-10 6 7 9 9 10 7 7 9 8 9 9 10
Interest 7 13 7 5 6 4 5 7 6 11 13 15 14
Depreciation 22 32 31 30 31 31 31 30 30 32 34 34 36
Profit before tax 77 243 165 187 115 116 124 122 76 81 80 55 51
Tax % 30% 31% 33% 31% 40% 31% 32% 25% 31% 29% 28% 30% 43%
54 168 111 129 69 79 84 92 52 58 57 39 29
EPS in Rs 3.41 10.56 6.96 8.10 4.31 4.98 5.29 5.75 3.28 3.62 3.61 2.42 1.84
Raw PDF
Upcoming result date: 16 July 2024

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0 684 4,949 4,773 4,136
0 567 4,108 4,224 3,715
Operating Profit -0 117 841 549 421
OPM % 17% 17% 11% 10%
0 -10 22 32 35
Interest 0 7 31 22 53
Depreciation 0 22 123 122 136
Profit before tax -0 77 709 437 268
Tax % 0% 30% 33% 30% 32%
-0 54 477 308 183
EPS in Rs -3.40 3.41 29.93 19.31 11.48
Dividend Payout % 0% 10% 17% 26% 43%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 82%
TTM: -13%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 42%
TTM: -41%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 2%
1 Year: 46%
Return on Equity
10 Years: %
5 Years: %
3 Years: 13%
Last Year: 7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 0 16 16 16 16
Reserves -0 1,907 2,417 2,650 2,722
0 556 238 407 740
0 888 1,111 1,176 1,254
Total Liabilities 0 3,366 3,782 4,249 4,732
0 1,805 1,798 1,846 2,539
CWIP 0 65 174 525 331
Investments 0 50 6 8 16
0 1,446 1,804 1,870 1,846
Total Assets 0 3,366 3,782 4,249 4,732

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0 112 453 462 430
0 33 -71 -469 -569
0 -72 -418 42 144
Net Cash Flow 0 73 -36 35 5

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 251 43 39 50
Inventory Days 601 117 146 160
Days Payable 685 103 113 131
Cash Conversion Cycle 167 57 72 80
Working Capital Days 269 59 61 64
ROCE % 8% 29% 16% 10%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
50.92% 50.92% 51.03% 51.10% 51.47% 51.47% 51.47% 51.47% 51.47% 51.47% 51.47% 51.47%
18.70% 11.11% 12.42% 11.21% 10.19% 9.24% 8.40% 7.73% 6.15% 6.30% 6.35% 6.58%
1.44% 0.81% 0.60% 0.67% 0.70% 2.36% 4.89% 5.97% 6.72% 9.18% 11.17% 13.60%
28.75% 36.97% 35.75% 36.82% 37.44% 36.72% 35.03% 34.62% 34.83% 32.22% 30.17% 27.53%
0.20% 0.20% 0.20% 0.20% 0.20% 0.20% 0.19% 0.19% 0.82% 0.82% 0.82% 0.81%
No. of Shareholders 95,2351,49,9391,81,8471,91,4771,93,8581,95,7041,86,8951,85,0621,86,2941,73,5331,62,2021,50,388

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls